Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EYPT NASDAQ:NVMI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYPTEyepoint Pharmaceuticals$14.72-0.8%$13.20$9.40▼$19.11$1.23B1.731.23 million shs748,498 shsNVMINova$476.91+0.6%$514.68$232.73▼$615.99$15.15B1.74420,483 shs89,070 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYPTEyepoint Pharmaceuticals+5.92%+6.15%+26.08%+4.58%+35.40%NVMINova+4.87%+0.82%-7.87%-4.45%+68.04%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYPTEyepoint Pharmaceuticals$14.72-0.8%$13.20$9.40▼$19.11$1.23B1.731.23 million shs748,498 shsNVMINova$476.91+0.6%$514.68$232.73▼$615.99$15.15B1.74420,483 shs89,070 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYPTEyepoint Pharmaceuticals+5.92%+6.15%+26.08%+4.58%+35.40%NVMINova+4.87%+0.82%-7.87%-4.45%+68.04%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEYPTEyepoint Pharmaceuticals 2.88Moderate Buy$44.29200.92% UpsideNVMINova 2.70Moderate Buy$551.2515.59% UpsideCurrent Analyst Ratings BreakdownLatest EYPT and NVMI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2026EYPTEyepoint Pharmaceuticals Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$47.007/7/2026NVMINova Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)7/6/2026NVMINova Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$494.00 ➝ $540.007/1/2026EYPTEyepoint Pharmaceuticals Chardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$29.00 ➝ $65.006/24/2026EYPTEyepoint Pharmaceuticals GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$68.005/15/2026NVMINova EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$600.005/15/2026NVMINova CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$520.00 ➝ $595.005/15/2026NVMINova BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$465.00 ➝ $600.005/14/2026NVMINova Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$520.00 ➝ $640.005/14/2026NVMINova Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C) ➝ Hold (C+)5/14/2026NVMINova Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$494.00(Data available from 7/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEYPTEyepoint Pharmaceuticals$7.61M162.06N/AN/A$3.70 per share3.98NVMINova$880.58M17.21$10.20 per share46.74$44.84 per share10.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEYPTEyepoint Pharmaceuticals-$231.96M-$3.50N/AN/AN/A-3,566.63%-110.54%-90.15%8/5/2026 (Estimated)NVMINova$259.22M$8.0259.4639.783.2729.21%21.77%12.56%8/6/2026 (Estimated)Latest EYPT and NVMI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026NVMINova$2.41N/AN/AN/A$250.33 millionN/A8/5/2026Q2 2026EYPTEyepoint Pharmaceuticals-$0.9471N/AN/AN/A$0.40 millionN/A5/14/2026Q1 2026NVMINova$2.20$2.33+$0.13$2.04$227.02 million$235.31 million5/6/2026Q1 2026EYPTEyepoint Pharmaceuticals-$0.79-$0.99-$0.20-$0.99$0.35 million$0.70 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthEYPTEyepoint PharmaceuticalsN/AN/AN/AN/AN/ANVMINovaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEYPTEyepoint PharmaceuticalsN/A6.666.63NVMINovaN/A1.581.39Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEYPTEyepoint Pharmaceuticals99.41%NVMINova82.99%Insider OwnershipCompanyInsider OwnershipEYPTEyepoint Pharmaceuticals5.13%NVMINova1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEYPTEyepoint Pharmaceuticals12083.84 million79.54 millionOptionableNVMINova1,61231.78 million31.47 millionOptionableEYPT and NVMI HeadlinesRecent News About These CompaniesNova Ltd. (NASDAQ:NVMI) Receives Average Rating of "Moderate Buy" from AnalystsJuly 10 at 3:41 AM | americanbankingnews.comNova Ltd. $NVMI Shares Purchased by Hsbc Holdings PLCJuly 9 at 3:59 AM | marketbeat.comBill Ackman Says Next $1 Trillion Company Will Come From Israel – ‘Imagine if Silicon Valley Was a Country'July 8 at 6:47 PM | benzinga.comGabriel Waisman Sells 2,966 Shares of Nova (NASDAQ:NVMI) StockJuly 8 at 5:09 AM | americanbankingnews.comMeitav Investment House Ltd. Increases Stock Position in Nova Ltd. $NVMIJuly 7 at 11:52 AM | marketbeat.comNova (NASDAQ:NVMI) CEO Sells 2,966 SharesJuly 7 at 8:52 AM | insidertrades.comMorgan Stanley Issues Positive Forecast for Nova (NASDAQ:NVMI) Stock PriceJuly 6, 2026 | marketbeat.comNova Sets August 6 Date to Announce Q2 2026 ResultsJuly 6, 2026 | tipranks.comNova to Report Second Quarter 2026 Financial Results on August 6July 6, 2026 | prnewswire.comNova Ltd. (NASDAQ:NVMI) Given Average Rating of "Moderate Buy" by AnalystsJuly 5, 2026 | marketbeat.comPictet Asset Management Holding SA Acquires 4,923 Shares of Nova Ltd. $NVMIJuly 4, 2026 | marketbeat.comNova Ltd.: Will Likely Ride The AI Wave Higher, So Keep HoldingJuly 3, 2026 | seekingalpha.comA Look at Nova Ltd (NVMI) After 6.5% Decline -- GF Value $308.26 vs Price $470.14July 3, 2026 | gurufocus.comNova WMC™ Expanding Adoption Across the Most Advanced Packaging ProcessesJuly 2, 2026 | prnewswire.comJames Investment Research Inc. Decreases Stock Position in Nova Ltd. $NVMIJuly 2, 2026 | marketbeat.comNova Ltd. (NVMI) Falls as Chip Stocks Retreat and No Fresh Company Catalyst EmergesJuly 1, 2026 | quiverquant.comQNova Ltd Stock GuidanceJune 30, 2026 | benzinga.comWasatch Advisors LP Sells 485,482 Shares of Nova Ltd. $NVMIJune 27, 2026 | marketbeat.comHsbc Holdings PLC Buys 13,160 Shares of Nova Ltd. $NVMIJune 27, 2026 | marketbeat.comNova (NASDAQ:NVMI) Shares Gap Down Following Insider SellingJune 26, 2026 | marketbeat.comYaniv Garty Sells 366 Shares of Nova (NASDAQ:NVMI) StockJune 26, 2026 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEYPT and NVMI Company DescriptionsEyepoint Pharmaceuticals NASDAQ:EYPT$14.72 -0.12 (-0.83%) As of 01:40 PM Eastern This is a fair market value price provided by Massive. Learn more.EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.Nova NASDAQ:NVMI$476.91 +2.92 (+0.62%) As of 01:40 PM Eastern This is a fair market value price provided by Massive. Learn more.Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. The company serves various sectors of the integrated circuit manufacturing industry, including logic, foundries, and memory manufacturers, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd. in July 2021. Nova Ltd. was incorporated in 1993 and is headquartered in Rehovot, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rocket Lab’s Stock Drop Comes With a Bullish Twist Micron's $250 Billion Bet Could Reshape the AI Memory Race AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth PepsiCo’s Dividend Could Turn Patience Into Real Profit Lockheed Martin Secures the Ultimate Defense Moat Why Levi's Digital Strategy Is Paying Off in a Big Way Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
